CoinVoice has learned that, according to Rockflow data, U.S. medical technology company ProPhase Labs rose over 35% during trading, with a market value increasing to $15.78 million. It had previously risen over 40% in pre-market trading. ProPhase Labs announced on July 21 that it is exploring a reverse merger with a company focused on cryptocurrency and will begin holding Bitcoin as part of a new digital asset reserve strategy. [Original link]